Comparative Pharmacology
Head-to-head clinical analysis: FERROUS FUMARATE versus TRILITRON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FERROUS FUMARATE versus TRILITRON.
FERROUS FUMARATE vs TRILITRON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Iron is an essential component of hemoglobin, myoglobin, and various enzymes; ferrous fumarate provides elemental iron for erythropoiesis and oxygen transport.
TRILITRON is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis and thereby alleviating pain and inflammation.
Oral: 200 mg (equivalent to 65 mg elemental iron) three times daily. Adults: 325 mg (106 mg elemental iron) one to three times daily.
10 mg orally once daily, with or without food.
None Documented
None Documented
5-7 hours for iron in serum after absorption; terminal half-life of storage iron (ferritin) is approximately 6 days; clinical context: follows first-order kinetics with iron recycling.
Terminal elimination half-life is 12-15 hours, allowing twice-daily dosing. Steady-state reached in 2-3 days.
Primarily fecal (about 90%) as unabsorbed iron; minor renal excretion (<1%) via sloughed intestinal cells and bile; negligible urinary elimination.
Primarily renal excretion of unchanged drug (60-70%) and glucuronide conjugate (15-20%). Biliary/fecal elimination accounts for 10-15%.
Category C
Category C
Iron Replacement
Iron Replacement